G. Bradley Cole, CFO at GENOMIC HEALTH INC (GHDX), sold 23,733 shares at $71.54 ($1.6M) on 2018-12-11, disclosed to the SEC on 2018-12-13.
Seasonal sale ($1.6M) by CFO — this insider has traded GHDX in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,633 | $0 | 0.0% |
| 2 | $70.58 | 2,529 | $178K | 11.3% |
| 3 | $70.58 | 2,529 | $178K | 11.3% |
| 4 | $70.61 | 1,400 | $99K | 6.2% |
| 5 | $71.53 | 2,200 | $157K | 9.9% |
| 6 | $71.54 | 4,571 |
| $327K |
| 20.6% |
| 7 | $71.54 | 4,571 | $327K | 20.6% |
| 8 | $72.73 | 700 | $51K | 3.2% |
| 9 | $73.10 | 600 | $44K | 2.8% |
| 10 | $73.56 | 900 | $66K | 4.2% |
| 11 | $74.42 | 800 | $60K | 3.8% |
| 12 | $74.61 | 1,300 | $97K | 6.1% |
| Total | $66.77 avg | 23,733 | $1.6M | 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |